Business Wire

Drive&Stake, the industry-first marketplace that empowers all mobility ecosystem participants to benefit from vehicle-generated data, launches today

2.11.2021 12:35:00 EET | Business Wire | Press release

Share

Drive&Stake, a decentralised, scalable end-to-end solution for the creation of automated mobility data marketplaces, promotes industry-wide data exchange and enables participants within the mobility ecosystem to obtain extensive insights through real-time data analytics.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211102005028/en/

Over the past decades, the traditional idea of everyone possessing their own car as the primary means of mobility has shifted towards more interconnected ride-sharing, car-sharing and autonomous (self-driving) vehicles. As a result, vehicles have become mobile hubs of data, generating and processing vast volumes of information. The generated data has the potential to become a key driver for the implementation of disruptive, data-driven business models and services.

However, the current infrastructure has limited communication with third-party frameworks, leaving data untapped and locked in centralised silos. As a consequence, original equipment manufacturers (OEMs) face a trade-off between opening up access to their data and retaining profits from exclusive control over it. Service providers, such as insurance or fleet management companies, are dependent on third-party analytics processes, while drivers have no control over produced data and its potential use.

Drive&Stake addresses these obstacles and empowers all participants in the mobility ecosystem to share, access and benefit from vehicle-generated data.

Service providers can reach a broader customer base, deliver enhanced customer experience, perform real-time settlement of liabilities and develop new products and features. OEMs can improve business processes and access consumer data in a transparent, auditable way, while drivers—in addition to more services at a lower cost—can enjoy a personalised customer experience and collect reward tokens for staking, consuming third-party services, swapping or exchanging for fiat currencies.

RIDDLE&CODE, the leading European blockchain interface company, is powering Drive&Stake with a flexible hardware stack and software-driven approach that unlocks data in a secure, confidential manner and tokenizes the produced data by pegging it to real-life objects. Ocean Protocol allows the exchange and monetisation of data and data-based services, overcoming the trade-off between the benefits of using private data and the risks of exposing it. Experts from EFS Consulting are transforming data into tangible use cases in close collaboration with vehicle manufacturers, mobility service providers, and insurance and energy corporations, while ELOOP has already deployed a successful use case, recording CO2 savings and mileage of electric vehicles.

“RIDDLE&CODE has built Confidential PID that enables the secure extraction of vehicle-generated data and controls how this data will be accessed and utilised,” said Thomas Fürstner, founder and CTO of RIDDLE&CODE. “This novel approach comes as a result of our extensive development efforts for other industries like fintech and energy, where RIDDLE&CODE successfully implements various encryption and trusted computing technologies,” he added.

“Curiosity for novel technologies is in the very DNA of EFS Consulting. We are delighted to channel this curiosity together with our partner RIDDLE&CODE,” said Christian Schaupp, Managing Director of EFS Consulting. “Drive&Stake is a project that reinvents the connected vehicle experience, and we are proud to be part of it. Together with RIDDLE&CODE and other industry-leading partners, we are creating new decentralised business models and services based on tokenized mobility data.”

“RIDDLE&CODE is a blockchain pioneer. They've been at the forefront of using trusted and verifiable IoT devices integrated with blockchains,” said Bruce Pon, CEO of Ocean Protocol. “Drive&Stake data will be a valuable addition to the Ocean Market and we’re very excited to create a new data economy together.”

“As a company committed to taking the sharing economy to the next level, ELOOP is delighted to be part of Drive&Stake. Today, we are deploying a first use case, recording CO2 savings and mileage of electric vehicles, and are keen to test and develop further use cases within the Drive&Stake ecosystem,” said Leroy Hofer, CEO at ELOOP.

Drive&Stake supports a variety of use cases, including pay-as-you-drive, networked parking for car-sharing, incentivised mobility patterns, sustainable EV battery and supply-chain traceability. Further use cases can be developed and implemented.

Businesses interested in exploring disrupting mobility solutions and gaining value from vehicle-generated data can contact RIDDLE&CODE for more information about joining Drive&Stake.

About RIDDLE&CODE

RIDDLE&CODE is Europe’s leading company for blockchain interface solutions. The company develops hardware and software stacks that combine the security of smart cards with blockchain and the Internet of Things (IoT). Together with its tier-one clients and partners, which include Daimler, BMW, Wien Energie and leading Dutch crypto exchange LiteBit, RIDDLE&CODE brings new business models to the fintech, energy, mobility and materials industries.

More information: www.riddleandcode.com

About EFS Consulting

EFS Consulting was established based on the idea of creating modular platform strategies within the automotive industry. Today, the consultancy company with offices in Vienna and Shanghai has expanded beyond the automotive sector with fields of competencies covering all aspects of a technological product life cycle. EFS is dedicated to empowering clients on a global scale to deliver better products, production and market solutions.

More information: www.efs.consulting

About ELOOP

ELOOP is a Vienna-based car-sharing startup with a focus on green mobility solutions and environmental protection. The company has the vision to change the way people get around in urban areas and take the sharing economy to the next level. With the power of blockchain, ELOOP has tokenized the revenue of its Tesla fleet and shares it with all ELOOP ONE token holders. The fleet of ELOOP consists purely of Tesla electric vehicles.

More information: eloop.at/en

About Ocean Protocol

Ocean Protocol is an on-ramp for data services into crypto ecosystems, using datatokens. Each datatoken is a fungible ERC20 token to access a given data service. Ocean smart contracts, Ocean libraries and Ocean-powered front ends make it easy to publish data services (deploy and mint datatokens) and consume data services (spend datatokens). Therefore, Ocean provides decentralised access control. The Ocean Protocol Foundation has allocated 20 million Ocean tokens for funding initiatives, including the Data Economy Challenge.

More information: oceanprotocol.com

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Media contact:
Aysenur Yükselal Aji.
aysenur@riddleandcode.com

Contact: Sebastian Steinmayr
+43 162 2447167.

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Galderma Receives U.S. FDA Approval for Differin ® Epiduo ® Acne Gel Prescription-to-OTC Switch22.5.2026 19:25:00 EEST | Press release

Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) use in ages 12 years and older, marking a significant Prescription-to-OTC transition in acne care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522074280/en/ The U.S. FDA approves Differin® Epiduo® Acne Gel Prescription-to-OTC switch This milestone represents yet another example of Galderma’s unique Integrated Dermatology strategy, demonstrating how proven innovations from its Therapeutic Dermatology portfolio can further strengthen its Dermatological Skincare offerings. The Prescription‑to‑OTC transition highlights Galderma’s scale and expertise in successfully commercializing dermatology innovations across the full spectrum of acne care. With the appro

Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 17:18:00 EEST | Press release

Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522186975/en/ Adam Plich, CEO and Co-Founder of Avanzanite Bioscience. “Thalassaemia is a complex, chronic and multisystem disease characterised by anaemia, ineffective erythropoiesis and haemo

ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 15:30:00 EEST | Press release

OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future

Enhertu ® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 15:00:00 EEST | Press release

Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority

Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 14:45:00 EEST | Press release

Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, signalling a shift in health systems from late-stage treatment to earlier intervention. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522587414/en/ Selected from 393 submissions across 68 countries, the winning teams were recognised through the inaugural ‘Future Health Challenge 2026: Building Anticipatory Health Systems through Population Sensing’, delivered by Future Health – A Global Initiative by Abu Dhabi in collaboration with MIT Solve. Health systems globally are facing rising costs and persistent delays in diagnosis, with many conditions still identified only after symptoms become severe. At the sam

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye